Company / Working Capital per Share
Phathom Pharmaceuticals, Inc. Working Capital per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$1.41
FY2025
5-year range
$1.41 / $8.65
FY2021-FY2025
Trend
-70.1%
vs FY2024
Sector context
#173 of 210
Health Care
What the data says
Phathom Pharmaceuticals, Inc.'s working capital per share of $1.41 is lower than 82% of companies in the Health Care sector (FY2025). Working Capital per Share has fluctuated over the past 8 years, ranging from $-0.21 in FY2018 to $22.16 in FY2019.
Based on SEC 10-K filings.
1.41 in FY2025 with a 5-year CAGR of -27.6%.
Declined from $8.65 to $1.41 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -25.6%
- 5-Year CAGR
- -27.6%
- 10-Year CAGR
- -
Sector benchmark
-98.8% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 70.1% year-over-year.
- Ranks #173 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2019.
- Lowest working capital per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -6.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.41 | -70.1% |
| FY2024 | $4.73 | -45.3% |
| FY2023 | $8.65 | +152.0% |
| FY2022 | $3.43 | -24.2% |
| FY2021 | $4.53 | -36.2% |
| FY2020 | $7.10 | -68.0% |
| FY2019 | $22.16 | +10526.5% |
| FY2018 | -$0.21 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026